Based off rapid magnetic resonance imaging (MRI), the AI-enabled MuscleView reportedly offers 3D analysis of muscle volume, muscle asymmetry and intramuscular fat.
The Food and Drug Administration (FDA) has granted 510(k) clearance for MuscleView, which provides three-dimensional (3D) visualization and analysis of muscle health based on artificial intelligence (AI) assessment of rapid magnetic resonance imaging (MRI) scans.
The MuscleView software enables enhanced assessment of muscle volume and asymmetry as well as intramuscular fat percentage and bone volume, according to Springbok Analytics, the manufacturer of the MuscleView software.
The newly FDA-cleared MuscleView software provides 3D visualization and analysis of muscle asymmetry and volume, intramuscular fat percentage and bone volume through AI-powered interpretation of rapid MRI scans. (Image courtesy of Springbok Analytics.)
The company says the capability of the MuscleView software, developed over 13 years of research, enables clinicians to have simplified 3D imaging of musculature and analysis of rapid MRI data, creating a “new standard” in muscle health assessment.
"We envision a future where a Springbok scan becomes a routine part of annual health check-ups and an integral part of preventive health — with scans even more frequent depending on performance goals, injuries and recovery, or other health considerations," noted Scott Magargee, the CEO and co-founder of Springbok Analytics. "Our goal is to empower individuals to better understand, monitor, and measure their muscle health across all stages of life."
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.